Program
Albumin-Bound Paclitaxel
Also written as “ABI-007”, “nab-paclitaxel” and “Nab-paclitaxel”.
Its studies are mostly in Pancreatic Neoplasms · Breast Neoplasms · Carcinoma, Non-Small-Cell Lung · Triple Negative Breast Neoplasms · Melanoma, led by 11 companies.
Drug pageAlbumin-Bound Paclitaxel: every studyMany companies study it; this page follows only the 51 they lead. All 527 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Bristol-Myers Squibb | 380 open or running | phase 4since May 28, 2014 | Sep 30, 2002 | none ahead |
| CSPC Pharmaceutical Groupits history only | 31 open or running | phase 3since Aug 15, 2017 | Aug 15, 2017 | none ahead |
| Theriva Biologics SLits history only | 20 open or running | phase 1since Jan 21, 2014 | Jan 21, 2014 | none ahead |
| Academic Thoracic Oncology Medical Investigators Consortiumits history only | 10 open or running | phase 2since Mar 24, 2016 | Mar 24, 2016 | none ahead |
| Astellas Pharmaits history only | 10 open or running | phase 1since Nov 6, 2009 | Nov 6, 2009 | none ahead |
| EBG MedAustronits history only | 11 open or running | no phasesince May 10, 2021 | May 10, 2021 | Dec 31, 2026NCT04894643 |
| Lee's Pharmaceuticalits history only | 10 open or running | phase 1since Sep 8, 2020 | Sep 8, 2020 | none ahead |
| Novartisits history only | 10 open or running | phase 2since Jul 1, 2008 | Jul 1, 2008 | none ahead |
| NovoCureits history only | 10 open or running | phase 2since Feb 29, 2024 | Feb 29, 2024 | none ahead |
| Otsukaits history only | 10 open or running | phase 2since Apr 16, 2008 | Apr 16, 2008 | none ahead |
| SynerGene Therapeuticsits history only | 11 open or running | phase 2since Dec 18, 2014 | Dec 18, 2014 | Dec 2026phase 2 · NCT02340117 |
Also a collaborator on its studies: Gilead Sciences, Pfizer, Criterium and Shanghai Pharmaceuticals.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Bristol-Myers Squibb only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 23 studies since Sep 30, 2002.
- Aug 28, 2013Phase 2 study in MelanomaNCT01933061
- Sep 27, 2013Phase 2 study in NeuroblastomaNCT01962103 · 107 enrolled · United States, Canada, France and more
- Oct 14, 2013Phase 3 study in Pancreatic NeoplasmsNCT01964430 · 866 enrolled · United States, Australia, Austria and more
- Dec 5, 2013Phase 2 study in Pancreatic NeoplasmsNCT02017015 · 83 enrolled · China
- Jan 2, 2014Phase 3 study in Carcinoma, Squamous CellNCT02027428 · 427 enrolled · United States, Germany, Italy and more
- Mar 31, 2014Phase 2 study in Colorectal NeoplasmsNCT02103062 · 41 enrolled · France
- May 28, 2014Phase 4 study in Carcinoma, Non-Small-Cell LungNCT02151149 · 143 enrolled · United States
- Sep 24, 2014Phase 2 study in Carcinoma, Non-Small-Cell LungNCT02250326 · 240 enrolled · United States, Canada, France and more
- Oct 1, 2014Phase 1 study in Pancreatic NeoplasmsNCT02267707 · 1 enrolled · United States, Germany
- Nov 10, 20142 phase 2 studiesNCT02289456, NCT02301143
- Dec 3, 2014Phase 1 study in Breast NeoplasmsNCT02309177 · 114 enrolled · United States
- Nov 30, 2015Phase 1 study in Pancreatic NeoplasmsNCT02620800 · 12 enrolled · United States
- Jun 9, 2017Phase 2 study in Colorectal NeoplasmsNCT03184870 · 332 enrolled · United States, Australia, Belgium and more
- Nov 6, 2017Phase 2 study in Advanced Pancreatic CancerNCT03336216 · 205 enrolled · United States, Canada, Denmark and more
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 38 Bristol-Myers Squibb leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT03336216Advanced Pancreatic Cancer · United States, Canada, Denmark and more | 2 | Completed | Jun 1, 2023 | 205 |
| NCT03184870Colorectal Neoplasms · United States, Australia, Belgium and more | 2 | Completed | Apr 6, 2023 | 332 |
| NCT02620800Pancreatic Neoplasms · United States | 1 | Completed | Oct 29, 2018 | 12 |
| NCT02309177Breast Neoplasms · United States | 1 | Completed | Sep 12, 2018 | 114 |
| NCT02301143Pancreatic Neoplasms · United States, Canada, France and more | 2 | Completed | Nov 21, 2017 | 107 |
| NCT02289456Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | Feb 22, 2017 | 40 |
| NCT02267707Pancreatic Neoplasms · United States, Germany | 1 | Terminated | Feb 10, 2016 | 1 |
| NCT02250326Carcinoma, Non-Small-Cell Lung · United States, Canada, France and more | 2 | Completed | Jul 17, 2017 | 240 |
| NCT02151149Carcinoma, Non-Small-Cell Lung · United States | 4 | Completed | Jul 14, 2017 | 143 |
| NCT02103062Colorectal Neoplasms · France | 2 | Completed | Nov 10, 2014 | 41 |
| NCT02027428Carcinoma, Squamous Cell · United States, Germany, Italy and more | 3 | Completed | Sep 15, 2017 | 427 |
| NCT02017015Pancreatic Neoplasms · China | 2 | Completed | Jun 1, 2015 | 83 |
| NCT01964430Pancreatic Neoplasms · United States, Australia, Austria and more | 3 | Completed | Jun 30, 2022 | 866 |
| NCT01962103Neuroblastoma · United States, Canada, France and more | 2 | Completed | Dec 5, 2017 | 107 |
| NCT01933061Melanoma | 2 | Withdrawn | Jan 2014 | 0 |
| NCT01881230Breast Neoplasms · United States, Australia, Austria and more | 3 | Completed | Oct 28, 2016 | 191 |
| NCT00864253Melanoma · United States, Australia, Canada and more | 3 | Completed | Jun 1, 2012 | 529 |
| NCT00844649Pancreatic Neoplasms · United States, Australia, Austria and more | 3 | Completed | Sep 17, 2012 | 861 |
| NCT00540514Carcinoma, Non-Small-Cell Lung · United States, Canada | 3 | Completed | Oct 1, 2009 | 1,052 |
| NCT00518284Peripheral Vascular Diseases · United States | 2 | Terminated | Aug 2009 | 6 |
| NCT00456846Breast Neoplasms · Canada | 2 | Terminated | Dec 11, 2012 | 123 |
| NCT00407407Fallopian Tube Neoplasms · United States | 1 | Terminated | Feb 1, 2008 | 6 |
| NCT00398086Pancreatic Neoplasms · United States | 2 | Completed | Sep 1, 2008 | 67 |
| NCT00394251Breast Neoplasms · United States | 2 | Completed | Mar 1, 2007 | 197 |
| NCT00394082Breast Neoplasms · United States | 2 | Completed | Sep 1, 2009 | 50 |
| NCT00281528Breast Neoplasms · United States, Puerto Rico | 2 | Terminated | Jul 1, 2010 | 208 |
| NCT00274456Breast Neoplasms · Ukraine | 2 | Completed | Mar 1, 2008 | 302 |
| NCT00274443Carcinoma, Non-Small-Cell Lung · Russian Federation | 2 | Completed | Jun 1, 2007 | 250 |
| NCT00249002Hemodialysis Graft Dysfunction · United States | 2 | Terminated | Nov 1, 2007 | 9 |
| NCT00140140Neoplasm Metastasis · United States | 2 | Terminated | Feb 2008 | 16 |
| NCT00124943Coronary Restenosis | 2 | Completed | Aug 2009 | 112 |
| NCT00107094Breast Neoplasms · United States | 1 | Completed | 30 | |
| NCT00093145Breast Neoplasms · United States | 2 | Completed | Oct 1, 2008 | 32 |
| NCT00093119Melanoma · United States | 2 | Completed | Feb 2005 | 75 |
| NCT00073723Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | 75 | |
| NCT00046527Breast Neoplasms · United States | 3 | Completed | 460 | |
| NCT00046514Breast Neoplasms · United States | 2 | Completed | 100 | |
| NCT00046423Neoplasms · United States | 1 | Completed | 20 |
How it is read
Names in the registry
- “ABI-007”, 15 entries
- “nab-paclitaxel”, 13 entries
- “Nab-paclitaxel”, 12 entries
- “Nab-Paclitaxel”, 9 entries
- “nab-Paclitaxel”, 6 entries
Conditions, from the studies’ own filings
- Pancreatic Neoplasms, 24 studies
- Breast Neoplasms, 14 studies
- Carcinoma, Non-Small-Cell Lung, 11 studies
- Triple Negative Breast Neoplasms, 4 studies
- Melanoma, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.